Tuttle Capital Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Tuttle Capital Management, LLC

  • $10.3 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$2.2 - $4.2 $12,896 - $24,620
-5,862 Reduced 30.02%
13,664 $33,000
Q1 2022

May 04, 2022
BUY
$2.83 - $8.69 $15,816 - $48,568
5,589 Added 40.1%
19,526 $79,000
Q4 2021

Jan 19, 2022
BUY
$8.31 - $14.92 $115,816 - $207,940
13,937 New
13,937 $116,000

Others Institutions Holding DNA

# of Institutions
43
Shares Held
48.4M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Tuttle Capital Management, LLC Portfolio

Follow Tuttle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tuttle Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email